Ryvu Therapeutics SA’s share price is zł30.25. Its GF Value is zł86.63. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Ryvu Therapeutics SA stock is .
The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.
In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:
| Price: zł30.25 | GF Value | Price/GF Value | ||
|---|---|---|---|---|
| Current | zł86.63 | 0.35 | ||
| Next FY1 End | zł89.86 | 0.34 | ||
| Next 12 Month | zł94.19 | 0.32 | ||
| Next FY2 End | zł97.33 | 0.31 |
GuruFocus performed a correlation analysis comparing Ryvu Therapeutics SA's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.
The findings reveal that Ryvu Therapeutics SA's stock price shows no significant correlation with any of these four metrics.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
